Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06859723

High Potency Cannabis: Acute and Protracted Effects

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of California, Los Angeles · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to assess the effects of smoked cananbis when cannabis is smoked during periods of cannabis use as usual and after a brief period of abstinence.

Detailed description

This outpatient study will assess the acute pharmacodynamic effects of smoked cannabis with \~50 mg and \~100 mg THC compared to placebo (\~0 mg THC) and whether a brief period of abstinence alters these effects. Metabolism (pharmacokinetics) of THC will be examined to associate behavioral and physiological effects to plasma concentrations of THC and metabolites.

Conditions

Interventions

TypeNameDescription
DRUGPlacebo Comparator: PlaceboPlacebo
DRUGLow dose THCSmoked low dose THC
DRUGHigh dose THCSmoked high dose THC

Timeline

Start date
2025-07-03
Primary completion
2027-07-01
Completion
2028-07-01
First posted
2025-03-05
Last updated
2025-10-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06859723. Inclusion in this directory is not an endorsement.

High Potency Cannabis: Acute and Protracted Effects (NCT06859723) · Clinical Trials Directory